Key Record Dates
ClinicalTrials.gov Identifier: | NCT04675294 |
---|---|
Brief Title: | Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) |
First Submitted : | December 15, 2020 |
First Submitted that Met QC Criteria : | December 15, 2020 |
First Posted : | December 19, 2020 |
Last Update Submitted that Met QC Criteria : | March 21, 2024 |
Last Update Posted : | March 22, 2024 |